Description of the FinnMedi company, an internationally operating company located in Finland and providing services related to research commercialization, business development and clinical research in the Life Sciences sector.

1. Finn-Medi Campus ’Innovation Platform for future health and well-being’ Fastest Growing Life Science Center in Finland

2. Topics
•Finn-Medi Campus
•FinnMedi Oy
•Future
•Programmes
•Lessions learned
•Contact information
•Questions

3. 18.9.2014
© FinnMedi Oy
3
•A combination of multi-disciplinary, technological, bio-medical and medical expertise
•Gathers experts and service in education, research, healthcare and business.
•The most efficient operational environment in Finland, Finn-Medi campus
•Highest growth in jobs
•New building (7000-10000 m2) every 2. year
•Top science
Fastest Growing Life Science Center

4. Milestones
•Establishment of Institute of Biotechnology at 1960’s (multidisciplinary approach)
•First technology center to Tampere, Hermia at 1980’s
•Project plans for Finn-Medi at 1990
•External threat 1992-1994 (closing medical school)
•Center of Expertise project and status at 1994
•Finn-Medi Technology Center and Finn-Medi Research (now FinnMedi Oy) start at 1995
•Next phases for technology center and Center of Expertise project at 1999
•BioneXt Tampere –program 2003-2010
•HealhBio and Wellness Cluster Programmes 2007-2013
•Innovative Cities 2014-2020

5. Finn-Medi Campus
• CLINICAL CORE
• Tampere University Hospital
• 2nd LAYER
• Clinical services COLLABORATION CIRCLE
• Science and Business Park
• Patient Hotel
• Other services
FM8
FM20

6. 18.9.2014
© FinnMedi Oy
6
Growth of Finn-Medi Campus
FM 1 1994
FM 3 2001
FM 2 1999
FM 4 2003
FM 5 2004
FM 6-7 2011
COXA 2002
Cancer hospital
2007
TaY 2009
TaY 2015
TAMK 2012
TAYS 2015
ACUTA 2009
TAYS 2013
FM 20-24 2015-
FM 8 2014

7. Tight Co-operation brings results
•Multidisciplinary co-operation with companies, researchers, investors and other interest groups.
•Parties eg:
–Tampere University Hospital, 4000 employees, 28 clinics
–University of Tampere, 2100 employees, strong medical research
–Tampere University of Technology, 1850 researchers, “University of industry”
–VTT Technical Research Centre of Finland, 2800 employees
–The City of Tampere
–The region’s business community and companies
–Coordination: FinnMedi Oy

8. 18.9.2014
© FinnMedi Oy
8
Life Science Expertise in Tampere
National capital in human spareparts, vaccines and bio-ICT

9. FOCUSED R&D
Biomedical engineering
•Biomaterials
•Implantable devices
•Cell culturing technolgy
BioICT
•Signal processing
•Imaging
•Biosensors
Cell biology
•Stem cells
•Cell models replacing animal testing
•Vaccines

10. CROSS-SCIENTIFIC COLLABORATION LEADS TO NEW THERAPIES
Eye related diseases
•Preservative-free eyedrop for glaucoma treatment
•Stem cell therapy for retinal pigment epithelium
Autoimmune
diseases
•Vaccine against HIV (phase I)
•Vaccine against diabetes type 1 (preclinical)
•Rapid diagnostic test for coeliac disease
Tissue repair and regenerative medicine
•Bioabsorbable implants for tissue repair
•Antibiotic releasing biodegrable implant
•Bone deficiency treatment with stem cells

11. © FinnMedi Oy
11
Biomaterials and tissue engineering
Hospital For Advanced Therapies
Finnish Tissue Bank,
FICAM
Spinoff companies
Biosensing Competence Center

12. Example of Research Excellence
BioMediTech: world leader in stem cell based reconstructions of cranial bones
•30 cases operated
•combination of biomaterials and stem cells differentiated from subcutaneous fat
2 months post op
28 months post op
• Nearly 20 M€ project funding for Human Spare parts program (2011-2015)
•Development of tissue engineering products and supporting technologies
•Tekes, Academy of Finland, Council of Tampere Region, EU

13. FinnMedi Oy Bringing companies closer to clinics
FinnMedi is an internationally operating company providing services related to research commercialization, business development and clinical research in the Life Sciences sector.

14. FinnMedi Oy Key Facts
•Founded 1995
•Personnel
•17 permanent specialists/experts
•approximately 100 project personnel annually
•Turnover 3,3 M€ (2012)
•Owners
•Pirkanmaa Hospital District
•City of Tampere
•Industrial Research Fund at Tampere University of Technology
•Tampere University Foundation
•Finnish Red Cross

15. FinnMedi Oy references
•the quantity of clinical trials over 500
•the volume of research grant agreements (e.g. EU) totally over 100 M€
•seeking of private and public funding for companies worth of 15 M€
•business idea evaluations over 300
•market and customer need analyses over 100
•business development projects for start-up and growth companies over 50
•business coaching for researchers and inventors over 50
•regulatory and quality system consultancies over 30

16. FinnMedi Services
Innovation
Clinical
Growth
•Idea Analysis
•Funding Expert
•Start-Up Coach
•Match Maker
•Business Analysis
•Business Coach
•Quality Expert
•Clinical Expert
•Investigator Recruitment
•Trial Documents & Submissions
•Site Administration

17. The customers using our Innovation services are research institutions, researchers and other business or product idea owners.
Using our services, customers are able to make the most efficient utilization of the commercial potential of their research and business idea.
Innovation
•Idea Analysis
•Funding Expert
•Start-Up Coach
•Match Maker

18. Growth is a service entity intended for growth companies to develop their business and quality, regulatory and clinical research processes.
Customers benefit through an improved realisation of their growth plans.
Growth
•Business Analysis
•Business Coach
•Quality Expert
•Clinical Expert

19. Clinical is a service package for companies focusing on research and product development, offering clinical research and product development in accordance with applicable quality systems.
Using Clinical services, customers quickly and reliably obtain the information they need to evaluate and improve the safety, efficiency and functionality of their products.
In clinical research services our clients have direct access to the investigators.
Clinical
•Investigator Recruitment
•Trial Documents & Submissions
•Site Administration

20. 18.9.2014
FinnMedi Oy
20
Clinical Trial Networks
FINN- TRIALS
FINNMEDI
ECRIN/ Nordic Trial Alliance
NATIONAL HUBS
NATIONAL
HUBS
NATIONAL HUBS
NATIONAL
HUBS
NATIONAL
HUBS
HELSINKI,
UNIVERSITY HOSPITAL DISTRICT
TURKU, UNIVERSITY HOSPITAL DISTRICT
TAMPRERE, UNIVERSITY HOSPITAL DISTRICT
KUOPIO, UNIVERSITY HOSPITAL DISTRICT
OULU,
UNIVERSITY HOSPITAL DISTRICT
OTHER RESEARCH ORGANISATIONS
NATIONAL
HUB
Project Tasks

21. Future
18.9.2014
© FinnMedi Oy
21

22. Gap between needs and resources. New technologies for personalized and effective healthcare. Raise of preventive care.
Value driven intervention, eHealth, on-line policlinics, crowd-sourcing, new combinations of services
Customer is decisionmaker.
More private funding to get health or wellness.
Understanding motivational factors are nesessary to get people to take care of themselves.
Analysis
To deliver value is the key.
Technology, science and competent people are available.
Need for new health ecosystem.
Tampere has competence to be one of the integrators of new treatments and technologies.
International partnering is neccesary.
.
Action
Create innovation platforms.
Active networking and partnering.
Public-private partnerhips and new procurement procedures.
Flagship projects of change.
Measure impact of actitivities to the health
Consumerism
Capabities by ICT
High tech –
low cost

23. Towards New Health Ecosystem Breaking boundaries between organizations or technologies
From Illness to Health
’Health is state of fysical,
mental, and social
experience of each individual’
Self motivated care
Primary
care
’Specialized healthcare is less than 1 % of Life but
~75 % of health expenditure
– and increasing’

24. Main Goals
•Increase health and wellness of citizens
•Generate new jobs into renewing health ecosystem.
•Decrease pressure for public health and social services
•Create internationally competitive and attractive macro- region for international investments
Cost
Benefit
Benefit
Cost

25. Future
Health
Health Platforms
Advanced Care
International Health
- Health management
-Innovative procurement
-Co-creation platforms
-Pilots
-Breaking boundaries
-Role models of change
-Revolutionary services
-The best know-how
-International co-creation
-Proactive localization

26. 18.9.2014
© FinnMedi Oy
26
Technnology Park 1994-2012
Public hospital
-1994
Specialized Healthcare
BIOTECH
Tecnology
Companies
Specialized
Healthcare
Wellness
Life Science
Specialized Healthcare (+ Medical education and clinical research)
Open and Networked Value Chain
International Lively Campus
2013-
KIBS
Selfcare
Services
New Customers
New players

27. Tampere
university of
applied sciences
Tampere
university
Tampere
university
hospital
Green Care Park
> 500 M€ investments 5 000-10 000 sports clients >10 000 students >10 000 health professionals >10 000 patients
Business Park

28. Advanced Care – main topics
Personalized diag- nostics
Predictive diagnostics
Primary Health Care
Rehabilitation
Specia- lized Care
Health registers
Persona- lized pharma
Health Monito- ring
Preven- tion
Crowd- sourcing
Eye
Body
Mind
Heart
Sports& wellness

29. © FinnMedi Oy
29
Health and wellness services
Research, R&D and
–infrasructure
Education,
Conferences
Knowledge Intensive Business Services
Fun, Sports & Leasure
Shops,
Living
Breaking boundaries,
DUI,
Co-Creation leadership
and platforms
International collaboration

30. Innovative tenders/ First customer
Co-creation
Outsourcing
Defining roles
Public procurement
Public Platform
Existing Services
Innovation

31. 31
9/18/2014
Dimensions of Programmes and Change
Vision
Competences
Organization
Projects and activities
Collaboration
Resources
Commitment
Change-over

32. Principles of programmes
•Formulation of strategy
•Regional commitment => resources and support
•Focused technology transfer organization, FinnMedi Oy
•Continuous benchmarking
•Sisu and hard work
•Full-day middleman and planning service and seed money for projects
•Professional technology transfer and business development

33. • Create strong strategy (focus)
• Middleman and clustering -methods are effective for Life Science
• Win-win networking attitude
• Organize also professional Business Development
• Fund projects more than institutions
•Trust yourself - 5 years is a very short time to for break-even !
What we have learned (programmes)

34. Thank you! Contact CEO Matti Eskola matti.eskola@finnmedi.com +358 40 55 75355 www.finnmedi.com
18.9.2014
© FinnMedi Oy
34

35. Health Platforms
Advanced Care
International Health
Towards Healthies City in the World